Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation

The metabolism of vandetanib, a tyrosine kinase inhibitor used for treatment of symptomatic/progressive medullary thyroid cancer, was studied using human hepatic microsomes, recombinant cytochromes P450 (CYPs) and flavin-containing monooxygenases (FMOs). The role of CYPs and FMOs in the microsomal m...

Descripción completa

Detalles Bibliográficos
Autores principales: Indra, Radek, Pompach, Petr, Martínek, Václav, Takácsová, Paulína, Vavrová, Katarína, Heger, Zbyněk, Adam, Vojtěch, Eckschlager, Tomáš, Kopečková, Kateřina, Arlt, Volker Manfred, Stiborová, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679423/
https://www.ncbi.nlm.nih.gov/pubmed/31295928
http://dx.doi.org/10.3390/ijms20143392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679423/
https://www.ncbi.nlm.nih.gov/pubmed/31295928
http://dx.doi.org/10.3390/ijms20143392

Ejemplares similares